These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27786243)

  • 21. Occipital nerve stimulation: technical and surgical aspects of implantation.
    Trentman TL; Zimmerman RS; Dodick DW
    Prog Neurol Surg; 2011; 24():96-108. PubMed ID: 21422780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment.
    MaassenVanDenBrink A; Terwindt GM; van den Maagdenberg AMJM
    Genome Med; 2018 Feb; 10(1):10. PubMed ID: 29471874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurostimulation therapies for primary headache disorders: present and future.
    Magis D; Jensen R; Schoenen J
    Curr Opin Neurol; 2012 Jun; 25(3):269-76. PubMed ID: 22543428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Headache Pipeline: Excitement and Uncertainty.
    Rapoport AM; McAllister P
    Headache; 2020 Jan; 60(1):190-199. PubMed ID: 31889312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphenopalatine Ganglion Stimulation for Chronic Headache Syndromes.
    Vesper J; Santos Piedade G; Hoyer R; Slotty PJ
    Prog Neurol Surg; 2020; 35():105-115. PubMed ID: 32694255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromodulation for Chronic Daily Headache.
    Coppola G; Magis D; Casillo F; Sebastianelli G; Abagnale C; Cioffi E; Di Lenola D; Di Lorenzo C; Serrao M
    Curr Pain Headache Rep; 2022 Mar; 26(3):267-278. PubMed ID: 35129825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent watch: Migraine therapies targeting the CGRP pathway: intellectual property landscape.
    Fiala JL; Lowery D
    Nat Rev Drug Discov; 2016 Jan; 15(1):8-9. PubMed ID: 26669672
    [No Abstract]   [Full Text] [Related]  

  • 28. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromodulation in migraine.
    Arca KN; Lambru G; Starling AJ
    Handb Clin Neurol; 2024; 199():179-200. PubMed ID: 38307646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive pericranial nerve interventions.
    Ambrosini A; Schoenen J
    Cephalalgia; 2016 Oct; 36(12):1156-1169. PubMed ID: 27009564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of the Patient with Refractory Headache.
    Zagami AS
    Curr Pain Headache Rep; 2018 Mar; 22(4):23. PubMed ID: 29556828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromodulation of chronic headaches: position statement from the European Headache Federation.
    Martelletti P; Jensen RH; Antal A; Arcioni R; Brighina F; de Tommaso M; Franzini A; Fontaine D; Heiland M; Jürgens TP; Leone M; Magis D; Paemeleire K; Palmisani S; Paulus W; May A;
    J Headache Pain; 2013 Oct; 14(1):86. PubMed ID: 24144382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive neurostimulation methods for migraine therapy: The available evidence.
    Schoenen J; Roberta B; Magis D; Coppola G
    Cephalalgia; 2016 Oct; 36(12):1170-1180. PubMed ID: 27026674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
    Barbanti P; Aurilia C; Fofi L; Egeo G; Ferroni P
    Neurol Sci; 2017 May; 38(Suppl 1):31-35. PubMed ID: 28527063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous occipital region stimulation for intractable headache syndromes.
    Weiner RL
    Prog Neurol Surg; 2011; 24():77-85. PubMed ID: 21422778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromodulation in migraine: state of the art and perspectives.
    Magis D
    Expert Rev Med Devices; 2015 May; 12(3):329-39. PubMed ID: 25633885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphenopalatine ganglion interventions: technical aspects and application.
    Oluigbo CO; Makonnen G; Narouze S; Rezai AR
    Prog Neurol Surg; 2011; 24():171-179. PubMed ID: 21422787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal cord stimulation in cluster headache.
    Wolter T; Kaube H
    Curr Pain Headache Rep; 2013 May; 17(5):324. PubMed ID: 23504520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A good preoperative response to transcutaneous electrical nerve stimulation predicts a better therapeutic effect of implanted occipital nerve stimulation in pharmacologically intractable headaches.
    Nguyen JP; Nizard J; Kuhn E; Carduner F; Penverne F; Verleysen-Robin MC; Terreaux L; de Gaalon S; Raoul S; Lefaucheur JP
    Neurophysiol Clin; 2016 Feb; 46(1):69-75. PubMed ID: 26895733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly
    Przeklasa-Muszyńska A; Skrzypiec K; Kocot-Kępska M; Dobrogowski J; Wiatr M; Mika J
    Neurol Neurochir Pol; 2017; 51(2):127-134. PubMed ID: 28159327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.